secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001213900-26-040032
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences COO and Board Member Mark Hilz passes away at 67
--------------------------------------------------------------

- Mark Hilz, COO, Corporate Secretary and Board member, died April 1, 2026 after an illness.
- He served on the Board since 2013 and as COO/Secretary since March 2022.
- Company will not hire a new COO; no changes expected to business or FDA clearance plans.
- MyoVista wavECG 510(k) submission remains on track (submitted Dec 2025).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390026040032/0001213900-26-040032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390026040032/ea0285132-8k_heartsci.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-040032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer